Novel 5-substituted derivatives of 2'-deoxy-6-azauridine with antibacterial activity.
Sergey D NegryaOlga V EfremenkovaPavel N SolyevVladimir O ChekhovMaxim A IvanovIrina G SumarukovaInna L KarpenkoSergey N KochetkovLiudmila A AlexandrovaPublished in: The Journal of antibiotics (2019)
The emergence of new drug-resistant strains of bacteria necessitates the development of principally new antibacterial agents. One of the novel classes of antibacterial agents is nucleoside analogs. We have developed a fast and simple one-pot method for preparation of α- and β-anomers of 5-modified 6-aza- and 2-thio-6-aza-2'-deoxyuridine derivatives in high yields. 2-Thio derivatives demonstrated moderate activity against Mycobacterium smegmatis (MIC = 0.2-0.8 mM), Staphylococcus aureus (MIC = 0.03-0.9 mM) and some other Gram-positive bacteria. 2'-Deoxy-2-thio-5-phenyl-6-azauridine (2b) effectively suppressed the growth of Gram-negative bacteria Pseudomonas aeruginosa ATCC 27853 (MIC = 0.03 mM)-the one that causes diseases difficult to treat due to high resistance to antibiotics. 5'-Monophosphates of compounds 2a, b and 3a, b were docked into a binding site of Mycobacterium tuberculosis flavin-dependent thymidylate synthase (ThyX) enzyme. The molecular modeling demonstrates the possibility of binding of the 5-modified 2-thio-6-aza-2'-deoxyuridine 5'-monophosphates within the active site of the enzyme and thereby inhibiting the growth of the bacteria.
Keyphrases
- drug resistant
- mycobacterium tuberculosis
- acinetobacter baumannii
- pseudomonas aeruginosa
- staphylococcus aureus
- multidrug resistant
- silver nanoparticles
- molecular docking
- structure activity relationship
- gram negative
- biofilm formation
- escherichia coli
- cystic fibrosis
- signaling pathway
- anti inflammatory
- high intensity
- binding protein
- transcription factor
- essential oil